Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Martin E, Eichhorn"'
Autor:
Mohamed Hassan, Julia Zimmermann, Severin Schmid, Bernward Passlick, Julia Kovács, Rudolf Hatz, Hauke Winter, Laura V. Klotz, Martin E. Eichhorn, Till Markowiak, Karolina Müller, Gunnar Huppertz, Michael Koller, Hans-Stefan Hofmann, Michael Ried
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe role of cytoreductive surgery combined with hyperthermic intrathoracic chemotherapy (CRS+HITOC) for patients with secondary pleural metastases has scarcely been investigated.Patients and MethodsWe conducted a retrospective, multicentre
Externí odkaz:
https://doaj.org/article/1a7a8ac6698142aa8ff55e5f77c952ff
Autor:
Miriam Blasi, Martin E. Eichhorn, Petros Christopoulos, Hauke Winter, Claus Peter Heußel, Felix J. Herth, Rami El Shafie, Katharina Kriegsmann, Mark Kriegsmann, Albrecht Stenzinger, Helge Bischoff, Michael Thomas, Jonas Kuon
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Data are currently insufficient to support the use of adjuvant chemotherapy (ACT) after surgical resection for stage II or III non-small cell lung cancer (NSCLC) in patients aged ≥ 75 years. In this study we evaluated efficacy a
Externí odkaz:
https://doaj.org/article/1b53ff915d164d97a52c735bb73255f9
Autor:
Florian Eichhorn, Laura V. Klotz, Helge Bischoff, Michael Thomas, Felix Lasitschka, Hauke Winter, Hans Hoffmann, Martin E. Eichhorn
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Immunotherapies targeting the PD1/PD-L1 pathway have had a large impact on the treatment of advanced NSCLC. Concerning multimodality tumor therapy, only few trials until today have been performed investigating neoadjuvant treatmen
Externí odkaz:
https://doaj.org/article/50b5756cf3ef479797e0cc786108831c
Autor:
Laura V. Klotz, Yves Courty, Michael Lindner, Agnès Petit‐Courty, Anja Stowasser, Ina Koch, Martin E. Eichhorn, Ioannis Lilis, Alicia Morresi‐Hauf, Kristina A. M. Arendt, Mario Pepe, Ioanna Giopanou, Giannoula Ntaliarda, Sabine J. Behrend, Maria Oplopoiou, Valérie Gissot, Serge Guyetant, Sylvain Marchand‐Adam, Jürgen Behr, Jan‐Christian Kaiser, Rudolf A. Hatz, Anne‐Sophie Lamort, Georgios T. Stathopoulos
Publikováno v:
Cancer Medicine, Vol 8, Iss 4, Pp 1486-1499 (2019)
Abstract A comprehensive characterization of lung adenocarcinoma (LADC) clinical features is currently missing. We prospectively evaluated Caucasian patients with early‐stage LADC. Patients with LADC diagnosed between 2011 and 2015 were prospective
Externí odkaz:
https://doaj.org/article/a89f35a0d3da42bf97712614c7c2bd44
Autor:
Michael Ried, Mohamed Hassan, Bernward Passlick, Severin Schmid, Till Markowiak, Karolina Müller, Gunnar Huppertz, Michael Koller, Hauke Winter, Laura V Klotz, Rudolf Hatz, Julia Kovács, Julia Zimmermann, Hans-Stefan Hofmann, Martin E Eichhorn
Publikováno v:
Interdisciplinary CardioVascular and Thoracic Surgery.
Objectives Cytoreductive surgery and hyperthermic intrathoracic chemotherapy (HITOC) is effective on survival for patients with pleural metastatic thymic tumours. Methods Multicentre, retrospective analysis of patients with stage IVa thymic tumours t
Autor:
Claus P. Heussel, Martin E. Eichhorn, Katrin Hornemann, Daniela Gompelmann, Hans Hoffmann, Ralf Eberhardt, Konstantina Kontogianni, Sascha Dreher, Hauke Winter, Felix J.F. Herth, Johannes Haag
Publikováno v:
The Annals of Thoracic Surgery. 111:1858-1865
Background Bronchoscopic valve placement constitutes an effective endoscopic lung volume reduction (ELVR) therapy in patients with severe emphysema and low collateral ventilation. After the most destroyed lobe is occluded with valves, significant tar
Autor:
Rajkumar Savai, Florian Eichhorn, Inka Zoernig, Michael Thomas, Thomas Muley, Martin E. Eichhorn, Laura V. Klotz, Hauke Winter, Dirk Jaeger, Marc A. Schneider, Katharina Kriegsmann, Mark Kriegsmann, Helge Bischoff, Claus Peter Heussel, Hans Hoffmann, Uwe Haberkorn
Publikováno v:
Lung Cancer. 153:150-157
Objectives A phase II trial investigating the therapeutic effect of neoadjuvant programmed cell death 1 (PD-1) inhibitor pembrolizumab (MK-3475, KEYTRUDA®) administered prior to surgery for the treatment of non-small cell lung cancer (NSCLC) has bee
Autor:
Johanna Riedel, Helge Bischoff, Inn Chung, Marc A. Schneider, Michael Thomas, Manuel Feißt, Martin E. Eichhorn, Laura V. Klotz, Rajiv Shah
Publikováno v:
Clinical Lung Cancer. 22:142-146
Background In selected patients with early-stage malignant pleural mesothelioma (MPM), a multimodal therapy that includes surgical cytoreduction, chemotherapy, and/or radiotherapy is recommended. Several clinical trials have demonstrated the benefici
Autor:
Gerald Schmid-Bindert, Jens Vogel-Claussen, Sylvia Gütz, Joana Fink, Hans Hoffmann, Martin E. Eichhorn, Felix J.F. Herth
Publikováno v:
Respiration; international review of thoracic diseases. 101(11)
Lung cancer (LC) is the leading cause of cancer-related mortality worldwide, and early LC diagnosis can significantly improve outcomes and survival rates in affected patients. Implementation of LC screening programs using low-dose computed tomography
Autor:
Florian Eichhorn, Martin E. Eichhorn, Johannes Diers, Philip Baum, Laura V. Klotz, Hauke Winter, Johannes Haag, Armin Wiegering
Publikováno v:
Lung Cancer. 149:78-83
The literature reports that hospital caseload volume is associated with survival for lung cancer resection. The aim of this study is to explore this association in a nationwide setting according to individual hospital caseload volume of every inpatie